← Leaderboards
Sebastien Jacquemont
Boston Children'S Hospital
$3,077,817
Attributed
$8,178,820
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,178,820 · 3
By mechanism
U01$6,406,660 · 2
R01$1,772,160 · 1
Top collaborators
- Laura A. Almasy7 shared
- David C Glahn7 shared
- Carrie E Bearden3 shared
- Paul M Thompson3 shared
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Helen B. Tager-Flusberg$19,144,713
- Jane W. Newburger$29,827,102
- Sanjay Srivastava$27,960,573
- Charles Alexander Nelson$51,962,137
- Maitreyi Mazumdar$7,856,116
Others in their field
Other Emerging Leaders on “Copy Number Polymorphism”
- Erin Rooney Riggs · Broad Institute, Inc.$6,471,349
- Santhosh Girirajan · Pennsylvania State University, The$4,983,605
- Badri N Vardarajan · University Of Miami School Of Medicine$4,911,075
- Sangita Choudhury · Boston Children'S Hospital$4,819,644
- Carlos Lopez Jaramillo · University Of California Los Angeles$4,781,166
- Loes Marlein Olde Loohuis · University Of California Los Angeles$4,781,166
Research focus
Copy Number PolymorphismCohortGenetic VariantAutism Spectrum DisorderPsychopathologyRecurrenceAlgorithmsSchizophreniaGeneticPhenotypeVariantDimensionsPolygenic Risk ScoreGenesRare Genetic DisorderGenetic ArchitectureNeuropsychiatryEvaluationNeuropsychiatric DisorderSamplingDiagnosisPsychosesComplexMental Depression
Grant awards (15)
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics Initiative$521,182
R01 · FY2025 · MH · contact PI
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics Initiative$621,319
R01 · FY2024 · MH · contact PI
6/9: Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders.$104,923
U01 · FY2024 · MH · contact PI
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability$1,169,817
U01 · FY2023 · MH
Understanding Rare Genetic Variation and Disease Risk: A Global Neurogenetics Initiative$629,659
R01 · FY2023 · MH · contact PI
6/9: Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders.$106,003
U01 · FY2023 · MH · contact PI
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability$1,169,817
U01 · FY2022 · MH
Admin Supplement: Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability$154,000
U01 · FY2022 · MH
6/9: Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders.$105,463
U01 · FY2022 · MH · contact PI
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability$1,169,817
U01 · FY2021 · MH
6/9: Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders.$105,463
U01 · FY2021 · MH · contact PI
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability$991,442
U01 · FY2020 · MH
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability$178,375
U01 · FY2020 · MH
6/9: Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders.$105,463
U01 · FY2020 · MH · contact PI
Large-Scale Evaluation of the Effect of Rare Genetic Variants on Psychiatric Symptoms and Cognitive Ability$1,046,077
U01 · FY2019 · MH